In a recent study the authors found that together with KRAS and galectin 3, melanoma cells could induce a stem-like phenotype and resistance to chemotherapeutics via a TBK1 activated NFκ-B signalling pathway, which is involved in the activation of inflammation [54,55]. The gene discussed is KRAS; the disease is melanoma.